Metraipolis › archive › dc_dac2887d38fb

Transmetalation in Cancer Pharmacology — Europe PMC PMID:41303491

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41303491
DOI
10.3390/ijms262211008
License (as archived)
solo-consultazione
Archived
2026-11-08T14:06:00.413Z
SHA-256 of the archived text
7bae20d3fd0bf9c28f45e561562bba743f9197559c25674dbc3a99ec468e7655
Stable URL of this page
https://metraipolis.com/documento/dc_dac2887d38fb

How to cite

Transmetalation in Cancer Pharmacology — Europe PMC PMID:41303491 — Europe PMC (en), https://europepmc.org/article/MED/41303491 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dac2887d38fb (Metraipolis archive dc_dac2887d38fb, sha256 7bae20d3fd0bf9c28f45e561562bba743f9197559c25674dbc3a99ec468e7655)
BibTeX
@misc{dcdac2887d38fb,
  title = {Transmetalation in Cancer Pharmacology — Europe PMC PMID:41303491},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41303491},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dac2887d38fb; sha256 7bae20d3fd0bf9c28f45e561562bba743f9197559c25674dbc3a99ec468e7655},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41303491. Agents can read the archived copy with the MCP tool read_document.